INSILICO (03696.HK) -0.800 (-1.118%) Short selling $24.77M; Ratio 16.827% opened up 0.08% this morning (20th) and once peaked at HKD71.4. It last traded at HKD71.3, up 17.27%, with a volume of 6.2793 million shares, involving HKD426 million.The company announced that it had integrated its previously launched Target Identification Pro (TargetPro) and Target Identification Benchmark (TargetBench 1.0) into a framework that can further validate druggability.Related NewsJPM: Profit-taking in China Pharma Sector Presents Good Entry OpportunityAccording to the research results recently published by INSILICO in Scientific Reports, this framework delivered outstanding results in both benchmark testing and real-world target discovery workflows, further demonstrating its value as a standardized foundation for AI-driven target identification.In addition, TIGERMED (03347.HK) +0.440 (+1.064%) Short selling $6.45M; Ratio 9.369% has signed a strategic cooperation agreement with INSILICO, under which the two parties will engage in long-term strategic collaboration on clinical research for innovative drug products, leveraging AI to accelerate and enhance the efficiency of drug development.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-24 16:25.)
AASTOCKS Financial News